Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-71,334
Closed -$5.81M 167
2024
Q3
$5.81M Buy
71,334
+17
+0% +$1.36K 0.26% 72
2024
Q2
$5.3M Sell
71,317
-2,515
-3% -$189K 0.26% 69
2024
Q1
$5.76M Sell
73,832
-65
-0.1% -$4.84K 0.27% 68
2023
Q4
$5.28M Sell
73,897
-12,550
-15% -$874K 0.27% 69
2023
Q3
$6M Buy
86,447
+1,389
+2% +$105K 0.32% 60
2023
Q2
$6.89M Sell
85,058
-1,082
-1% -$88.4K 0.37% 56
2023
Q1
$6.95M Buy
+86,140
New +$6.93M 0.38% 60

Other funds holding HOLX

Seizert Capital Partners's HOLX Position: Q4 2024 in Review

Seizert Capital Partners sold out of Hologic (HOLX) in Q4 2024, closing a stake of 71,334 shares — an estimated $5.81M sold.

Seizert Capital Partners first reported a position in HOLX in Q1 2023 and held it in 7 quarters. The position peaked at $6.95M in Q1 2023. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Seizert Capital Partners reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Seizert Capital Partners sold 71,334 Hologic shares in Q4 2024, an estimated $5.81M.
  • Seizert Capital Partners first reported a position in Hologic in Q1 2023 and held it in 7 quarters.
  • Seizert Capital Partners's Hologic position peaked at $6.95M in Q1 2023.
  • 719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Seizert Capital Partners's 13F filing for Q4 2024, filed 6 Feb 2025.